Biogen Inc. buy Royal Bank of Canada
Start price
08.10.25
/
50%
€130.40
Target price
08.10.26
€186.64
Performance (%)
14.38%
Price
15:30
€149.15
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 14.38%. This prediction currently runs until 08.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 3.348% | 3.348% |
| iShares Core DAX® | -1,66 % | -10,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % |
| iShares S&P 500 | -2,30 % | -4,80 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $219.00 to $217.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat